On July 2, Tom Lee, Fundstrat's Head of Research and CIO, joined CNBC Television to discuss market conditions.
Keep Reading →
July 3 - Hedge Funds, News
On July 3rd, Dan Ives, Global Head of Tech Research at Wedbush, joined CNBC to discuss the technology sector.
Keep Reading →
July 3 - Hedge Funds, News
Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires.
Keep Reading →
July 3 - News
The H1 2025 has been a roller coaster ride for the investors.
Keep Reading →
July 2 - Hedge Funds, News
As expectations for trade agreements and potential rate cuts reduced investor anxiety, the S&P 500 and Nasdaq reached record closing highs on June 30, concluding their strongest...
Keep Reading →
June 30 - Hedge Funds, News
Merck & Co., Inc. (NYSE:MRK) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company shared encouraging results from its Phase 3 HYPERION trial.
Keep Reading →
June 28 - News
Merck & Co., Inc. (NYSE:MRK) is a leading pharmaceutical company, best known for its strong presence in oncology, particularly through Keytruda, the top-selling drug globally.
Keep Reading →
June 28 - News
One of the most read (and recommended) books on investing is Benjamin Graham’s The Intelligent Investor.
Keep Reading →
June 27 - Hedge Funds, News
Over the past two years, dividend stocks have lagged behind the broader market as investor interest shifted toward companies focused on artificial intelligence.
Keep Reading →
June 26 - Dividend Stocks, Hedge Funds, News
Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best and Cheap Stocks to Buy Now.
Keep Reading →
June 25 - News
Merck & Co., Inc. (NYSE:MRK) is another biopharmaceutical company on the list of the 10 undervalued blue chip stocks analysts recommend for smart investing.
Keep Reading →
June 24 - News
On June 4 Morningstar released its June 2025 outlook, indicating that as of May 30, the US stock market was trading at a 3% discount to its fair value.
Keep Reading →
June 23 - Hedge Funds, News
Investors have long favored dividend stocks for their financial strength and solid returns, which have historically outpaced many other asset classes.
Keep Reading →
June 23 - Dividend Stocks, Hedge Funds, News
Blue-chip stocks are great assets for investors looking for opportunities to grow their capital in the long term. Some call them steady oaks in the forest of finance.
Keep Reading →
June 20 - Hedge Funds, News
Merck & Co., Inc. (NYSE:MRK) is one of the best dividend stocks for dependable dividend growth.
Keep Reading →
June 18 - News
Merck & Co., Inc. (NYSE:MRK) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Cantor Fitzgerald reaffirmed its Neutral rating on Merck & Co., Inc.
Keep Reading →
June 17 - News
Health and Human Services Secretary Robert F. Kennedy Jr.
Keep Reading →
June 13 - News
The Bureau of Labor Statistics stated on June 11 that consumer prices increased less than anticipated in May given that President Donald Trump's tariffs had not yet had a noticeable...
Keep Reading →
June 12 - Hedge Funds, News
The medication is being studied as a potential treatment for hyperlipidemia, a condition marked by high levels of fat in the bloodstream.
Keep Reading →
June 11 - News
The Dow Jones Industrial Average, often called the Dow Jones or just the Dow, is a stock market index that tracks 30 major publicly traded companies in the United States.
Keep Reading →
June 11 - Hedge Funds, News
Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s preventative antibody shot received authorization from the U.S.
Keep Reading →
June 11 - News
A wide-moat stock is a company stock that maintains market leadership through a premium product, brand value, or corporate strategy.
Keep Reading →
June 10 - Hedge Funds, News
Bill Stone, Glenview Trust Company chief investment officer, mentioned his bullish take on Merck (NYSE:MRK) during a recent program on CNBC and explained the potential risks and...
Keep Reading →
June 5 - News
A new clinical trial has shown that combining Gilead Sciences, Inc. (NASDAQ:GILD)’s Trodelvy with Merck & Co., Inc.
Keep Reading →
May 31 - News
Jim Cramer in a recent program on CNBC commented on Merck & Co Inc.
Keep Reading →
May 30 - News
Artisan Partners, an investment management company, released its “Artisan Value Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
May 30 - Hedge Fund Investor Letters, News
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Value Investing Subreddit Page by CompanyCharts. In this article, we will summarize the bulls’ thesis on MRK.
Keep Reading →
May 21 - News, Stock Analysis
Chris Toomey, Morgan Stanley managing director of private wealth, said in a latest program on CNBC that he is not bullish on stocks yet and plans to “stay defensive” until...
Keep Reading →
May 19 - Hedge Funds, News
The last time the S&P erased a 15% decline in under six weeks was 1982, which tells a lot about the current market dynamics we are currently in.
Keep Reading →
May 14 - Hedge Funds, News
Dividend-paying stocks have been gaining popularity among investors due to their long-term advantages.
Keep Reading →
May 13 - Dividend Stocks, Hedge Funds, News
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
Keep Reading →
May 12 - Hedge Funds, Industries, News
As per Niamh Brodie-Machura, Co-Chief Investment Officer at Fidelity International, the effect of tariffs is expected to shift lower as and when the deals are made, supply chains...
Keep Reading →
May 10 - Hedge Funds, News
Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy.
Keep Reading →
May 10 - Dividend Stocks, Hedge Funds, News
The Dow Jones Industrial Average is a benchmark index of the top 30 companies in the US.
Keep Reading →
May 7 - News, Stock Analysis
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Investing Intel. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.
Keep Reading →
May 7 - News, Stock Analysis
Mario Gabelli needs no introduction, having risen to become one of the most successful money managers on Wall Street, backed by a research-driven equity investment style.
Keep Reading →
May 6 - Hedge Funds, News
US stocks rose on Friday, May 2, as the S&P 500, Dow Jones Industrial Average, and the tech-heavy Nasdaq all posted impressive gains.
Keep Reading →
May 3 - Hedge Funds, Industries, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the growing amount of stock buybacks and how the buybacks during April-May were the third best ...
Keep Reading →
April 30 - News
The Dow Jones Industrial Average (DJIA), or the Dow, is a price-weighted index that has long been seen as a barometer of the health of the U.S. economy.
Keep Reading →
April 30 - Hedge Funds, Industries, News
Cliff Asness, the founder, managing principal, and chief investment officer of AQR Capital Management, is a well-known figure in the world of finance.
Keep Reading →
April 30 - Hedge Funds, News
Blue chip stocks are under immense pressure amid the evolving trade tensions and tariff announcements around the globe.
Keep Reading →
April 29 - Hedge Funds, News
“These are hideous depressing days for the bulls. I'm not used to seeing a White House that doesn't seem to care that it's causing the decline.
Keep Reading →
April 27 - Hedge Funds, News
The healthcare industry, an essential component of global well-being and economic resilience, is undergoing significant changes.
Keep Reading →
April 26 - Business, Hedge Funds, News
Blue chip stocks are large, financially stable companies with strong market presence, consistent profitability, and regular dividend payments.
Keep Reading →
April 26 - Hedge Funds, News
Operator: Thank you for standing by. Welcome to the Merck & Co., Inc., Rahway, New Jersey U.S.A. Quarter 1 Sales and Earnings Conference Call. This call is being recorded.
Keep Reading →
April 26 - News, Transcripts